MinervaX
Clinical-stage biotechnology company developing a Group B Streptococcus (GBS) vaccine to prevent life-threatening infections in newborns through maternal immunization.
Website
https://www.minervax.comLocation
Copenhagen, Denmark
Founded
2010
Investors
1
Categories
vaccines, infectious-disease, maternal-health, biotech, neonatal
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Adjuvant Capital | Washington, DC, USA | biotech-focused | seedseries-a+3 | 16 |
